JB Chemicals gets USFDA nod to market generic medication

The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals Pharmaceuticals said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/5UdyCWS